Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
553 studies found for:    "Lupus"
Show Display Options
Rank Status Study
1 Terminated A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
Condition: Discoid Lupus
Interventions: Drug: CC-930;   Drug: Placebo
2 Completed Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
Condition: Lupus
Interventions: Biological: MEDI-545;   Biological: MEDI 545
3 Completed Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Condition: Lupus Nephritis
Intervention:
4 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
5 Completed Lupus Genetics Studies
Condition: Systemic Lupus Erythematosus
Intervention:
6 Withdrawn Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Rituximab
7 Active, not recruiting Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)
Condition: Lupus Nephritis
Intervention: Procedure: Renal Biopsy
8 Withdrawn Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: prednisolone;   Drug: Placebo
9 Terminated Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Conditions: Cutaneous Lupus;   Lupus
Interventions: Drug: AMG 557;   Drug: AMG 557 Placebo
10 Completed Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
Condition: Discoid Lupus Erythematosus
Interventions: Drug: ASF 1096 0.5 % cream applied twice daily;   Drug: Cream vehicle for ASF 1096 cream applied twice daily
11 Completed Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus+Mycophenolate mofetil;   Drug: Cyclophosphamide
12 Recruiting Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Gardasil
13 Unknown  Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Biological: mesenchymal stem cell
14 Recruiting RING - Rituximab for Lupus Nephritis With Remission as a Goal
Condition: Lupus Nephritis
Interventions: Drug: RTX infusions;   Other: Standard of Care
15 Unknown  Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Human Umbilical Cord derived MSCs;   Drug: Cyclophosphamide
16 Recruiting Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Brentuximab vedotin;   Drug: Placebo
17 Recruiting Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Anifrolumab;   Drug: Placebo
18 Completed Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Long-acting tacrolimus (Advagraf, Astellas Pharma)
19 Completed A Study to Evaluate the Efficacy and Safety of CEP-33457 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Lupuzor;   Drug: Placebo
20 Completed
Has Results
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Interventions: Drug: R932333;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.